Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?

Producción científica: Editorial

2 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)266-267
Número de páginas2
PublicaciónInternational Journal of Cardiology
Volumen250
DOI
EstadoPublished - ene 1 2018

Financiación

Dr. Pepine receives support from the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine; NIH/NHLBI--UFRCC for the Cardiovascular Cell Therapy Research Network and Training Core Supplement HL087366, Brain-Gut Microbiome-Immune Axis in Hypertension HL132448, and Angiotensin and Neuroimmune Activation in Hypertension HL033610; US Dept. of Defense CDRMP Ischemia-Intensive Medical Treatment Reduces Events in Women with Nonobstructive CAD PR161603; NIH NCATS—University of Florida Clinical and Translational Science UL1TR001427; and PCORnet-OneFlorida Clinical Research Consortium CDRN-1501-26,692.

FinanciadoresNúmero del financiador
Avedisian School of Medicine Department of Medicine
Gatorade Trust
NIH NCATS
UFRCCHL087366, HL132448
Clinical and Translational Science Institute, University of FloridaUL1TR001427
National Institutes of Health (NIH)
U.S. Department of Defense
National Heart, Lung, and Blood Institute (NHLBI)
Florida AandM University and Florida State University

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Huella

    Profundice en los temas de investigación de 'High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?'. En conjunto forman una huella única.

    Citar esto